April 9, 2019
Cerevel Therapeutics Announces Publication of Phase 2a Study Results in Neurology on Its Most Advanced Investigational Epilepsy Treatment
Findings Demonstrate Promising Anticonvulsant Activity with CVL-865, a Novel Selective GABA Potentiator, in Patients with Photosensitive Epilepsy Company to Initiate…